Aspira Pathlab & Diagnostics Limited share price
BSE: ASPIRA
Key numbers
- Market cap
- ₹ 134 Cr
- Current price
- ₹ 130.02
- 52-week high / low
- ₹ 139 / 49
- Stock P/E
- -
- Book value
- ₹ 11.9
- Dividend yield
- 0.00%
- ROCE
- 2.7%
- ROE
- 0.4%
- Debt to equity
- 0.16
- Sales growth (3 yrs)
- 20.0%
- Profit growth (3 yrs)
- -
- 1-year return
- 102.1%
About Aspira Pathlab & Diagnostics Limited
Aspira Pathlab & Diagnostics Limited owns, manages, runs, and administers various diagnostics centers primarily in India. The company offers biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigation services. It also provides pathology, sonography, x-ray, and radiology tests. The company was formerly known as Utkal Soap Products Limited and changed its name to Aspira Pathlab & Diagnostics Limited in November 2016. Aspira Pathlab & Diagnostics Limited was incorporated in 1973 and is based in Mumbai, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 5 | 8 | 5 | 7 | 6 |
| Operating profit | 1 | 2 | -1 | -0 | 0 |
| Net profit | 0 | 2 | -2 | -1 | -0 |
| EPS (₹) | 0.46 | 1.78 | -1.52 | -0.67 | -0.04 |
Peers in Diagnostics & Research
Data for information only, not investment advice. Prices end of day.